Family Office Of America (FOFA) EPS (Diluted) Growth (1y) (2022 - 2026)
Family Office Of America (FOFA) EPS (Diluted) Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.74 Bn | 176.45 Bn | 6.27 Bn | -18.71% |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn | 13.88% |
| 3 | Medtronic | 108.48 Bn | 99.26 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 68.51 Bn | 67.05 Bn | 3.61 Bn | 98.71% |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 95.96% |
| 7 | GE HealthCare Technologies | 28.23 Bn | 25.95 Bn | 1.98 Bn | -29.80% |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.47 Bn | 21.35 Bn | 2.07 Bn | 114.19% |
| 10 | Family Office Of America | 27.22 Mn | 26.88 Mn | 783,126.00 | 219.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 219.77% |
| Dec 31, 2025 | -507.41% |
| Sep 30, 2025 | -68.05% |
| Jun 30, 2025 | -133.09% |
| Mar 31, 2025 | -458.20% |
| Dec 31, 2024 | -101.35% |
| Sep 30, 2024 | 67.09% |
| Jun 30, 2024 | 99.21% |
| Mar 31, 2024 | 91.30% |
| Dec 31, 2023 | 592.63% |
| Sep 30, 2023 | 77.71% |
| Jun 30, 2023 | -212.26% |
| Mar 31, 2023 | 18.39% |
| Dec 31, 2022 | 59.50% |
| Sep 30, 2022 | 76.17% |
| Jun 30, 2022 | 39.24% |